MUC5B and interstitial lung disease: Further insights were provided by McDermott et al., who linked the MUC5B promoter variant to early onset RA-ILD, often manifesting before or within two years of RA diagnosis [85]; however, the MUC5B rs35705950 variant was not associated with the rate of pulmonary function decline in RA-ILD patients [86].